A citation-based method for searching scientific literature


List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
28

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
573
28

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
28

Clinical approach to Parkinson's disease: features, diagnosis, and principles of management.
João Massano, Kailash P Bhatia. Cold Spring Harb Perspect Med 2012
190
28

Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
Chen Qiao, Qian Zhang, Qingling Jiang, Ting Zhang, Miaomiao Chen, Yi Fan, Jianhua Ding, Ming Lu, Gang Hu. J Neuroinflammation 2018
43
28


Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
Marta Pajares, Ana I Rojo, Gina Manda, Lisardo Boscá, Antonio Cuadrado. Cells 2020
122
28

Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly.
Maila Giannandrea, Veronica Bianchi, Maria Lidia Mignogna, Alessandra Sirri, Salvatore Carrabino, Errico D'Elia, Matteo Vecellio, Silvia Russo, Francesca Cogliati, Lidia Larizza,[...]. Am J Hum Genet 2010
170
14

Neurochemical and motor changes in mice with combined mutations linked to Parkinson's disease.
Xiang Bai, Margaret Chia-Ying Wey, Paul Anthony Martinez, Chao Shi, Elizabeth Fernandez, Randy Strong. Pathobiol Aging Age Relat Dis 2017
7
14

The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
R de la Fuente-Fernández, M A Núñez, E López. Clin Neuropharmacol 1999
37
14

HOMER1 promoter analysis in Parkinson's disease: association study with psychotic symptoms.
Vincenzo De Luca, Grazia Annesi, E Valeria De Marco, Andrea de Bartolomeis, Giuseppe Nicoletti, Pierfrancesco Pugliese, Giovanni Muscettola, Paolo Barone, Aldo Quattrone. Neuropsychobiology 2009
23
14

Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease.
Erinaldo Ubirajara Damasceno Dos Santos, Elaine Bandeira Cavalcanti Duarte, Laura Maria Ramos Miranda, Amdore Guescel C Asano, Nadja Maria Jorge Asano, Maria De Mascena Diniz Maia, Paulo Roberto Eleutério de Souza. J Clin Pharmacol 2019
10
14

Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension.
Joachim Beige, Astrid Bellmann, Arya M Sharma, Reinhard Gessner. Am J Hypertens 2004
22
14


Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
David Devos, Stéphanie Lejeune, Florence Cormier-Dequaire, Khadija Tahiri, Fanny Charbonnier-Beaupel, Nathalie Rouaix, Alain Duhamel, Bernard Sablonnière, Anne-Marie Bonnet, Cecilia Bonnet,[...]. Parkinsonism Relat Disord 2014
37
14

The role of genetics in the etiology of schizophrenia.
Pablo V Gejman, Alan R Sanders, Jubao Duan. Psychiatr Clin North Am 2010
145
14

Transcriptional activation of the cholecystokinin gene by DJ-1 through interaction of DJ-1 with RREB1 and the effect of DJ-1 on the cholecystokinin level in mice.
Takuya Yamane, Sayaka Suzui, Hirotake Kitaura, Kazuko Takahashi-Niki, Sanae M M Iguchi-Ariga, Hiroyoshi Ariga. PLoS One 2013
15
14


Identification of TMEM230 mutations in familial Parkinson's disease.
Han-Xiang Deng, Yong Shi, Yi Yang, Kreshnik B Ahmeti, Nimrod Miller, Cao Huang, Lijun Cheng, Hong Zhai, Sheng Deng, Karen Nuytemans,[...]. Nat Genet 2016
119
14

Clinical Features of LRRK2 Carriers with Parkinson's Disease.
Meir Kestenbaum, Roy N Alcalay. Adv Neurobiol 2017
24
14

The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease.
Yujing Gao, Gabrielle R Wilson, Sarah E M Stephenson, Kiymet Bozaoglu, Matthew J Farrer, Paul J Lockhart. Mov Disord 2018
32
14

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.
A W Charney, D M Ruderfer, E A Stahl, J L Moran, K Chambert, R A Belliveau, L Forty, K Gordon-Smith, A Di Florio, P H Lee,[...]. Transl Psychiatry 2017
105
14


Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Mike A Nalls, Nathan Pankratz, Christina M Lill, Chuong B Do, Dena G Hernandez, Mohamad Saad, Anita L DeStefano, Eleanna Kara, Jose Bras, Manu Sharma,[...]. Nat Genet 2014
14

The significance of GBA for Parkinson's disease.
Kathrin Brockmann, Daniela Berg. J Inherit Metab Dis 2014
22
14


Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy.
Anna Fedosova, Nataliya Titova, Zarema Kokaeva, Natalia Shipilova, Elena Katunina, Eugene Klimov. J Pers Med 2021
2
50

The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women.
Frédéric Limosin, Jean-Yves Loze, Claudette Boni, Louis-Philippe Fedeli, Michel Hamon, Frédéric Rouillon, Jean Adès, Philip Gorwood. Neurosci Lett 2004
36
14

What's in a Gene? The Outstanding Diversity of MAPT.
Daniel Ruiz-Gabarre, Almudena Carnero-Espejo, Jesús Ávila, Vega García-Escudero. Cells 2022
1
100

Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
D G Le Couteur, P W Leighton, S J McCann, S m Pond. Mov Disord 1997
83
14

Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
L Gao, F J Díaz-Corrales, F Carrillo, J Díaz-Martín, M T Caceres-Redondo, M Carballo, A Palomino, J López-Barneo, P Mir. Acta Neurol Scand 2010
31
14

Risk factors for non-motor symptoms in Parkinson's disease.
Johan Marinus, Kangdi Zhu, Connie Marras, Dag Aarsland, Jacobus J van Hilten. Lancet Neurol 2018
121
14

APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology.
Dennis W Dickson, Michael G Heckman, Melissa E Murray, Alexandra I Soto, Ronald L Walton, Nancy N Diehl, Jay A van Gerpen, Ryan J Uitti, Zbigniew K Wszolek, Nilüfer Ertekin-Taner,[...]. Neurology 2018
82
14

5-HT2A receptor gene polymorphism and negative symptoms in first episode (drug-naive) Chinese Han nationality individuals with schizophrenia.
Yu-hong Wang, Wen-qiang Li, Zhao Huang, Yu-zhong Shi, Xu-Yi Wang, Jin-song Huang, Xu-hui Zhou, Hong-xian Chen, Wei Hao. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008
2
50

Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease.
Artur F Schumacher-Schuh, Carolina Francisconi, Vivian Altmann, Thais L Monte, Sidia M Callegari-Jacques, Carlos Rm Rieder, Mara H Hutz. Int J Neuropsychopharmacol 2013
16
14

Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
B Bembi, S Zambito Marsala, E Sidransky, G Ciana, M Carrozzi, M Zorzon, C Martini, M Gioulis, M G Pittis, L Capus. Neurology 2003
106
14

Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
Bernard Ravina, Karen Marder, Hubert H Fernandez, Joseph H Friedman, William McDonald, Diane Murphy, Dag Aarsland, Debra Babcock, Jefferey Cummings, Jean Endicott,[...]. Mov Disord 2007
284
14

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.
A F Schumacher-Schuh, V Altmann, M Rieck, L Tovo-Rodrigues, T L Monte, S M Callegari-Jacques, M S Medeiros, C R M Rieder, M H Hutz. Pharmacogenomics J 2014
19
14

Clinical studies of neuroinflammatory mechanisms in schizophrenia.
Crystal C Watkins, Sarah Ramsay Andrews. Schizophr Res 2016
45
14

Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
Assaf Halperin, Deborah Elstein, Ari Zimran. Blood Cells Mol Dis 2006
96
14

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.
Lorenzo Kiferle, Roberto Ceravolo, Lucia Petrozzi, Carlo Rossi, Daniela Frosini, Anna Rocchi, Gabriele Siciliano, Ubaldo Bonuccelli, Luigi Murri. Neurosci Lett 2007
26
14

The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson's Disease.
Pauline Mencke, Ibrahim Boussaad, Chiara D Romano, Toshimori Kitami, Carole L Linster, Rejko Krüger. Cells 2021
12
14



The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
Jun Zhang, Yiqing Song, Honglei Chen, Dongsheng Fan. Eur Neurol 2005
39
14

H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population.
P Z Almos, S Horváth, A Czibula, I Raskó, B Sipos, P Bihari, J Béres, A Juhász, Z Janka, J Kálmán. Heredity (Edinb) 2008
11
14

RAB39B gene mutations are not linked to familial Parkinson's disease in China.
Ji-Feng Kang, Yang Luo, Bei-Sha Tang, Chang-Min Wan, Yang Yang, Kai Li, Zhen-Hua Liu, Qi-Ying Sun, Qian Xu, Xin-Xiang Yan,[...]. Sci Rep 2016
9
14

MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Kevin H Strang, Todd E Golde, Benoit I Giasson. Lab Invest 2019
101
14


Parkinson's disease and parkinsonism: neuropathology.
Dennis W Dickson. Cold Spring Harb Perspect Med 2012
405
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.